Journal of Pharmacology and Experimental Therapeutics 2023

3 papers
The 2023 edition of the Journal of Pharmacology and Experimental Therapeutics featured research focused on molecular pharmacology and the optimization of therapeutic interventions. Key studies explored the mechanisms of signaling pathways in various disease models and drug responses. Notable contributions included an investigation into optimizing interferon-alpha therapy for myeloproliferative neoplasms and a study on how specific ligands achieve biased signaling at opioid receptors. Research also addressed the complexities of drug tolerance, specifically examining the regulation of cAMP signaling by endothelin-A receptor antagonists in the context of morphine tolerance. These works highlight a thematic emphasis on G protein-coupled receptor (GPCR) dynamics and the development of more targeted pharmacological strategies. Prolific contributors to the year's volume included researchers such as Gurvan Hermange, Isabelle Plo, and Ron O. Dror, whose work spans hematological oncology and molecular neuropharmacology.

Top Research Directions

The 3 research directions with Journal of Pharmacology and Experimental Therapeutics 2023 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Hierarchical Bayesian Parameter Estimation through Partial Pooling133.3%
2Overcoming Data Scarcity in Rare Disease Research133.3%
3Streaming Calibration for Dynamic Data Driven Simulations133.3%

Download all directions as CSV

Institutions

Institutions credited by Journal of Pharmacology and Experimental Therapeutics 2023 papers: a paper credits every institution named in its affiliations, once. 4 institutions share 1 credited papers.

#InstitutionPapersShare
1CentraleSupélec 1100.0%
2Inserm 1100.0%
3Institut Gustave Roussy 1100.0%
4Université Paris-Saclay 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Pharmacology and Experimental Therapeutics 2023 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Pharmacology and Experimental Therapeutics 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-pharmacology-and-experimental-therapeutics/2023.

Top Authors

AuthorPapers
Carl-Mikael Suomivuori1
Ron O. Dror1

Papers

Title
How ligands achieve biased signaling at opioid receptors
Optimizing IFN Alpha Therapy against Myeloproliferative Neoplasms
Regulation of cAMP Signaling by Endothelin-A Receptor Antagonist, BQ123 in Morphine Tolerance in SH-SY5Y Human Neuroblastoma Cells